Dr. Valdez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1650 Selwyn Ave Fl 9
Bronx, NY 10457Phone+1 718-960-1020Fax+1 718-960-2033- Is this information wrong?
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1994 - 1998
Henry Ford HospitalResidency, Internal Medicine, 1991 - 1994
Cayetano Heredia UniversityClass of 1990
Certifications & Licensure
NY State Medical License 2004 - 2023
Clinical Trials
- The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
- Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
- A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
- Join now to see all
Publications & Presentations
PubMed
- 122 citationsIncidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and f...Philip J. Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel M. Kremer, Jeff Greenberg, Wendi Malley, Alina Onofrei, Keith...> ;Annals of the Rheumatic Diseases. 2020 Aug 5
- 190 citationsEfficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Melinda Gooderham, Gary Chan, Claire Feeney, Pinaki Biswas, Hernan Valdez, Marco DiBonaventura, Chudy I. Ndu...> ;JAMA Dermatology. 2020 Aug 1
- 155 citationsEfficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-...Eric L. Simpson, Rodney Sinclair, Seth Forman, Andreas Wollenberg, Roland Aschoff, Michael J. Cork, Thomas Bieber, Jacob P. Thyssen, Gil Yosipovitch, Carsten Flohr, Ni...> ;Lancet. 2020 Jul 25
- Join now to see all
Journal Articles
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
Authored Content
- Modified- Versus Immediate-Release Tofacitinib in Japanese Rheumatoid Arthritis Patients: A Randomized, Phase III, Non-Inferiority StudyAugust 2018
Press Mentions
One More Phase 3 Trial Finds Abrocitinib Safe, Effective for Atopic DermatitisJune 13th, 2020- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 3rd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
